As of January 23, 2025, FibroBiologics (FBLG) has a market cap of $59.496 million USD. According to our data, FibroBiologics is ranked No.8052 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $59.50 M |
-15.50%
|
Dec 31, 2024 | $70.41 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Market Cap | = | FBLG Stock Price | * | FBLG Shares Outstanding |
= | $1.69 | * | 35.20 M | |
= | $59.50 M |